Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MDCX is expected to report earnings to rise 190.48% to -61 cents per share on November 20
Q3'26
Est.
$-0.61
Q2'26
Beat
by $0.40
Q1'26
Beat
by $0.30
Q4'25
Missed
by $0.38
Q3'25
Missed
by $0.90
The last earnings report on August 12 showed earnings per share of -20 cents, beating the estimate of -61 cents. With 697.34K shares outstanding, the current market capitalization sits at 10.91M.